ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

AGIO Agios Pharmaceuticals Inc

46,30
-1,67 (-3,48%)
Após o horário de negociação
Última atualização: 19:58:30
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Agios Pharmaceuticals Inc AGIO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-1,67 -3,48% 46,30 19:58:30
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
48,15 46,62 48,34 46,77 47,97
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/06/202410:00GLOBEUpdated Time: Agios to Present at the Goldman Sachs 45th..
03/06/202407:30GLOBEAgios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met..
30/05/202417:05GLOBEAgios to Present at the Goldman Sachs 45th Annual Global..
28/05/202408:00GLOBEAgios Announces $905 Million Purchase Agreement for..
14/05/202411:00GLOBEAgios Pharmaceuticals to Present Clinical and Translational..
06/05/202408:00GLOBEAgios to Present at the BofA Securities 2024 Health Care..
03/05/202408:00GLOBEAgios to Present at the RBC Capital Markets Global..
02/05/202408:00GLOBEAgios Reports Business Highlights and First Quarter 2024..
18/04/202408:00GLOBEAgios to Webcast Conference Call of First Quarter 2024..
09/04/202408:00GLOBEAgios Publishes 2024 Environmental, Social and Governance..
05/03/202409:00GLOBEAgios to Present at the Leerink Partners Global Biopharma..
22/02/202409:00GLOBEAgios to Present at the TD Cowen 44th Annual Health Care..
15/02/202409:00GLOBEAgios Reports Fourth Quarter and Full Year 2023 Financial..
02/02/202409:00GLOBEAgios to Webcast Conference Call of Fourth Quarter and Year..
08/01/202409:00GLOBEAgios Announces Key Anticipated 2024 Milestones Across Rare..
03/01/202408:30GLOBEAgios Announces Phase 3 ENERGIZE Study of Mitapivat Met..
02/01/202409:00GLOBEAgios to Present at the 42nd Annual J.P. Morgan Healthcare..
09/12/202321:00GLOBEAgios Presents Positive Results from Phase 2 Portion of the..
20/11/202309:00GLOBEAgios Announces Clinical Proof-of-Concept in Phase 2a Trial..
02/11/202310:05GLOBEAgios Pharmaceuticals to Present Broad Set of Clinical and..
02/11/202308:00GLOBEAgios Reports Business Highlights and Third Quarter 2023..
29/08/202308:00GLOBEAgios to Present at the Morgan Stanley Global Healthcare..
03/08/202307:35GLOBEAgios Reports Business Highlights and Second Quarter 2023..
03/08/202307:30GLOBEAgios Announces Exclusive Worldwide License Agreement for..
13/07/202308:00GLOBEAgios to Webcast Conference Call of Second Quarter 2023..
26/06/202307:30GLOBEAgios Announces Positive Results from Phase 2 Portion of..